Tracking vision changes in dry age-related macular degeneration
Part of Eyes & vision clinical trials.
This study observes how dry age-related macular degeneration (AMD) changes over time using regular eye exams. It may help doctors better understand the natural pattern of progression and which patients are more likely to worsen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 50 to 85 years old
- You have dry age-related macular degeneration (not wet/active), at an early, intermediate, or intermediate-to-late stage
- You do not have other eye diseases that would make retinal exams hard to interpret
- You do not have a “research eye” with choroidal neovascularization (new abnormal blood vessel growth) or very high nearsightedness
- You can safely complete follow-up visits (for example, no major memory or thinking problems that affect staying in the study)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a vision treatment approach for people age 50+ who have dry age-related macular degeneration (AMD) and are legally blind from it. It aims to see whether the treatment can improve vision-related outcomes in the study eye.
This trial tests an investigational drug called SCT520FF for people with wet age-related macular degeneration (nAMD). It aims to find the safest dose and check if it can improve vision. You may be eligible if you have active new blood vessels in your eye from nAMD and have not had certain other eye problems.
This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.
This study tracks how age-related macular degeneration (AMD) progresses over time and looks at factors that might affect your vision and quality of life. By participating, you'll help researchers understand more about AMD and what might predict better or worse outcomes.
This study looks closely at how age-related macular degeneration (AMD) develops and changes over time by taking detailed eye measurements. It may help researchers better understand disease progression, especially for people who already have AMD.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
Hear when a new Dry Age-related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.